# Study of ARC-520 in Patient With Chronic Hepatitis B Virus

> **NCT02349126** · PHASE2 · WITHDRAWN · sponsor: **Arrowhead Pharmaceuticals**

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** ARC-520 Injection

## Key facts

- **NCT ID:** NCT02349126
- **Lead sponsor:** Arrowhead Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-02
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision to pursue alternative clinical trial
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349126, "Study of ARC-520 in Patient With Chronic Hepatitis B Virus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02349126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*